Erratum: Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65))

Hope S. Rugo; Jens Huober; José A. García-Sáenz; Norikazu Masuda; Joo Hyuk Sohn; Valerie A.M. Andre; Susana Barriga; Joanne Cox; Matthew Goetz

doi:10.1002/onco.13691

Erratum: Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65))

Hope S. Rugo, Jens Huober, José A. García-Sáenz, Norikazu Masuda, Joo Hyuk Sohn, Valerie A.M. Andre, Susana Barriga, Joanne Cox, Matthew Goetz

Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	e522
Journal	The oncologist
Volume	26
Issue number	3
DOIs	https://doi.org/10.1002/onco.13691
State	Published - Mar 1 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.1002/onco.13691

Cite this

Rugo, H. S., Huober, J., García-Sáenz, J. A., Masuda, N., Sohn, J. H., Andre, V. A. M., Barriga, S., Cox, J., & Goetz, M. (2021). Erratum: Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65)). The oncologist, 26(3), e522. https://doi.org/10.1002/onco.13691

Erratum: Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65)). / Rugo, Hope S.; Huober, Jens; García-Sáenz, José A. et al.
In: The oncologist, Vol. 26, No. 3, 01.03.2021, p. e522.

Research output: Contribution to journal › Comment/debate › peer-review

Rugo, HS, Huober, J, García-Sáenz, JA, Masuda, N, Sohn, JH, Andre, VAM, Barriga, S, Cox, J & Goetz, M 2021, 'Erratum: Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65))', The oncologist, vol. 26, no. 3, pp. e522. https://doi.org/10.1002/onco.13691

Rugo HS, Huober J, García-Sáenz JA, Masuda N, Sohn JH, Andre VAM et al. Erratum: Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65)). The oncologist. 2021 Mar 1;26(3):e522. doi: 10.1002/onco.13691

Rugo, Hope S. ; Huober, Jens ; García-Sáenz, José A. et al. / Erratum : Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65)). In: The oncologist. 2021 ; Vol. 26, No. 3. pp. e522.

@article{1ef6cb9af1e8424bb56ecf8e6212050d,

title = "Erratum: Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65))",

author = "Rugo, {Hope S.} and Jens Huober and Garc{\'i}a-S{\'a}enz, {Jos{\'e} A.} and Norikazu Masuda and Sohn, {Joo Hyuk} and Andre, {Valerie A.M.} and Susana Barriga and Joanne Cox and Matthew Goetz",

year = "2021",

month = mar,

day = "1",

doi = "10.1002/onco.13691",

language = "English (US)",

volume = "26",

pages = "e522",

journal = "The oncologist",

issn = "1083-7159",

publisher = "AlphaMed Press",

number = "3",

}

TY - JOUR

T1 - Erratum

T2 - Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65))

AU - Rugo, Hope S.

AU - Huober, Jens

AU - García-Sáenz, José A.

AU - Masuda, Norikazu

AU - Sohn, Joo Hyuk

AU - Andre, Valerie A.M.

AU - Barriga, Susana

AU - Cox, Joanne

AU - Goetz, Matthew

PY - 2021/3/1

Y1 - 2021/3/1

UR - http://www.scopus.com/inward/record.url?scp=85102482333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102482333&partnerID=8YFLogxK

U2 - 10.1002/onco.13691

DO - 10.1002/onco.13691

M3 - Comment/debate

C2 - 33660385

AN - SCOPUS:85102482333

SN - 1083-7159

VL - 26

SP - e522

JO - The oncologist

JF - The oncologist

IS - 3

ER -

Erratum: Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 (The oncologist (2021) 26 1 (e53-e65))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this